THERMALIN DIABETES, INC.

Company Information

Company Name
THERMALIN DIABETES, INC.
Address
10000 Cedar Avenue
CLEVELAND, OH, -
Phone
n/a
URL
n/a
DUNS
802601570
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$2,039,539.00
4
SBIR Phase II
$4,469,515.00
1
STTR Phase I
$254,997.00
1
Chart code to be here

Award List

  1. Halogenated Insulin: a fast-acting, ultra stable analog.

    Amount: $392,091.00

    DESCRIPTION (provided by applicant): A Phase 1 SBIR program of pre-clinical development is proposed focusing on a novel rapid-acting insulin analog for the treatment of diabetes mellitus. Designated I ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. A Novel 'Zinc-Stapled' Long-Acting Insulin Analog

    Amount: $423,635.00

    DESCRIPTION (provided by applicant): A Phase 1 SBIR program of pre-clinical development is proposed focusing on a novel long-acting insulin analog for the basal treatment of diabetes mellitus. Designa ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Clinical Testing of an Insulin Analog

    Amount: $254,997.00

    DESCRIPTION (provided by applicant): The central goal of insulin replacement therapy in the treatment of Type 1 diabetes mellitus (T1DM) is tight control of blood glucose concentration. This Phase I ...

    STTR Phase I 2009 Department of Health and Human Services
  4. Optimized Receptor Binding Profile in an Ultra-Stable, Ultra-Rapid-Acting Insulin

    Amount: $622,539.00

    DESCRIPTION (provided by applicant): We seek to develop an ultra-fast, zinc-free insulin analog formulation for the treatment of diabetes mellitus. An ultra-fast pharmacokinetic-dynamic (PK/PD) profil ...

    SBIR Phase I 2011 Department of Health and Human Services
  5. Chlorolog: Production Scaling and Testing of a Fast-Acting, Ultra-stable Insulin

    Amount: $4,469,515.00

    DESCRIPTION (provided by applicant): We seek to develop a novel insulin analog to enhance the safety and efficacy of insulin pump therapy with broad application to the Artificial Pancreas Project ( s ...

    SBIR Phase II 2012 Department of Health and Human Services
  6. Manipulating Aromaticity: characterization of an ultra-rapid insulin analog

    Amount: $601,274.00

    DESCRIPTION (provided by applicant): We seek to develop an ultra-fast insulin analog formulation for the treatment of diabetes mellitus. Ultra-fast pharmacokinetic/dynamic (PK/PD) promises to enable s ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government